Femme et Homme
- | Pays :
- Germany
- | Organes : -
- | Spécialités : -
Extrait
After 2 weeks of run-in period, subjects are randomized to either IQP-CL-101 or a matching placebo. Over 8 weeks, the subjects are monitored for improvements in IBS symptoms
Critère d'inclusion
- Irritable bowel syndrome